Assembly Biosciences (ASMB) Net Equity Issued and Repurchased (2011 - 2025)
Assembly Biosciences (ASMB) posted quarterly Net Equity Issued and Repurchased of $1.9 million for Q1 2025, down 5.32% quarter-over-quarter from $2.0 million in Q4 2024.
Assembly Biosciences (ASMB) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
Assembly Biosciences' Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2025.
- In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $1.9 million (down 5.32% YoY), while the FY2025 annual figure was $1.9 million, down 5.32% from the prior year.
- Net Equity Issued and Repurchased for Q1 2025 stood at $1.9 million, down from $2.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $34.1 million in Q1 2021, with the low at $54000.0 in Q2 2023.
- The 5-year median for Net Equity Issued and Repurchased is $2.6 million (2021), against an average of $6.8 million.
- The sharpest annual moves came in 2021 and 2022: Net Equity Issued and Repurchased sank 52.33% in 2021, then sank 87.5% in 2022.
- Assembly Biosciences' Net Equity Issued and Repurchased stood at $2.6 million in 2021, then tumbled by 87.5% to $325000.0 in 2022, then plunged by 83.38% to $54000.0 in 2023, then surged by 3659.26% to $2.0 million in 2024, then fell by 5.32% to $1.9 million in 2025.
- Business Quant data shows ASMB's Net Equity Issued and Repurchased at $1.9 million in Q1 2025, $2.0 million in Q4 2024, and $54000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.92 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Jun 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 4.49 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 325,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 2.60 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 10.06 Mn |
| Sep 30, 2021 | 10.06 Mn |
| Jun 30, 2021 | 6.02 Mn |
| Jun 30, 2021 | 6.02 Mn |
| Mar 31, 2021 | 34.14 Mn |
| Mar 31, 2021 | 34.14 Mn |
| Dec 31, 2020 | 5.45 Mn |
| Dec 31, 2020 | 5.45 Mn |